Literature DB >> 10024581

Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms.

J F Downing1, D L Kachel, R Pasula, W J Martin.   

Abstract

Pneumocystis carinii pneumonia remains a serious complication for immunocompromised patients. In the present study, P. carinii organisms interacted with gamma interferon (IFN-gamma)-stimulated alveolar macrophages (AMs) to activate the L-arginine-dependent cytocidal pathway involving reactive nitrogen intermediates (RNI) that were assayed as nitrite (NO2-). Unstimulated cultures of AMs produced negligible quantities of RNI. Addition of P. carinii organisms to IFN-gamma-primed AMs resulted in greatly enhanced production of RNI. NO2- levels increased from 0.8 +/- 0.4 to 11.1 +/- 3.8 microM as early as 6 h after P. carinii organisms were incubated with IFN-gamma-stimulated AMs and to 35.1 +/- 8.9 microM after a 24-h incubation, a near-maximum level. High levels of NO2- were produced by AMs primed with as little as 10 U of IFN-gamma per ml in the presence of P. carinii, and a 20-fold increase in IFN-gamma concentration resulted in only a further 65% increase in NO2- production. RNI-dependent killing of P. carinii was demonstrated by both a 51Cr release assay and a [35S]methionine pulse immunoprecipitation assay. Addition of either monoclonal tumor necrosis factor alpha (TNF-alpha) neutralizing antibody or 200 microM NG-monomethyl-L-arginine (L-NGMMA), a competitive inhibitor of the L-arginine-dependent pathway, significantly decreased NO2- production and reduced P. carinii killing. TNF-alpha alone had no effect on P. carinii viability. These results suggest that (i) the specific interaction of P. carinii organisms with IFN-gamma-primed AMs triggers the production of RNI, (ii) RNI are toxic to P. carinii, and (iii) TNF-alpha likely plays a central role in mediating P. carinii killing by IFN-gamma-stimulated AMs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024581      PMCID: PMC96467     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages.

Authors:  M P Sherman; M L Loro; V Z Wong; D P Tashkin
Journal:  J Protozool       Date:  1991 Nov-Dec

Review 2.  Pulmonary infectious complications of human immunodeficiency virus infection. Part II.

Authors:  J F Murray; J Mills
Journal:  Am Rev Respir Dis       Date:  1990-06

3.  Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.

Authors:  J M Beck; H D Liggitt; E N Brunette; H J Fuchs; J E Shellito; R J Debs
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.

Authors:  H W Murray; B Y Rubin; H Masur; R B Roberts
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

5.  Long-term survival of patients with AIDS, Pneumocystis carinii pneumonia, and respiratory failure.

Authors:  Y Friedman; C Franklin; S Freels; M H Weil
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

6.  Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.

Authors:  W Chen; E A Havell; A G Harmsen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.

Authors:  F Torrico; H Heremans; M T Rivera; E Van Marck; A Billiau; Y Carlier
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro.

Authors:  E L Pesanti
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

10.  Evaluation of nitrite production by human monocyte-derived macrophages.

Authors:  E L Padgett; S B Pruett
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

View more
  13 in total

1.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice.

Authors:  M Wu; S Hussain; Y H He; R Pasula; P A Smith; W J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

4.  B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.

Authors:  Michael M Opata; Zhan Ye; Melissa Hollifield; Beth A Garvy
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

5.  Ethanol (EtOH)-induced TGF-β1 and reactive oxygen species production are necessary for EtOH-induced alveolar macrophage dysfunction and induction of alternative activation.

Authors:  Sheena D Brown; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2012-05-02       Impact factor: 3.455

6.  Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia.

Authors:  Vijayalakshmi Nandakumar; Deanne Hebrink; Paige Jenson; Theodore Kottom; Andrew H Limper
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

7.  Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Chung-Ping Liao; Chadi A Hage; Pamela J Durant; Dennis Tschang; Shao-Hung Wang; Chen Zhang; Chao-Hung Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-17       Impact factor: 6.914

8.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

9.  Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia.

Authors:  Shao-Hung Wang; Chen Zhang; Mark E Lasbury; Chung-Ping Liao; Pamela J Durant; Dennis Tschang; Chao-Hung Lee
Journal:  Microbes Infect       Date:  2007-12-28       Impact factor: 2.700

10.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.